Rekah Pharmaceutical Industry Stock

Rekah Pharmaceutical Industry Employees 2025

Rekah Pharmaceutical Industry Employees

434

Ticker

REKA.TA

ISIN

IL0010810096

In 2025, Rekah Pharmaceutical Industry employed 434 people, a 0% change from the 434 number of employees in the previous year.

Rekah Pharmaceutical Industry Aktienanalyse

What does Rekah Pharmaceutical Industry do?

Rekah Pharmaceutical Industry ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Rekah Pharmaceutical Industry's Employee Base

Rekah Pharmaceutical Industry's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Rekah Pharmaceutical Industry's operational capacity and future potential.

Year-to-Year Comparison

Assessing Rekah Pharmaceutical Industry's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Rekah Pharmaceutical Industry's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Rekah Pharmaceutical Industry’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Rekah Pharmaceutical Industry stock

How many employees does Rekah Pharmaceutical Industry have this year?

Rekah Pharmaceutical Industry has 434 undefined employees this year.

How many employees did Rekah Pharmaceutical Industry have compared to the previous year?

Compared to the previous year, Rekah Pharmaceutical Industry had 0% more employees.

What impact did the number of employees have on the company Rekah Pharmaceutical Industry?

The number of employees has a direct impact on the efficiency and productivity of Rekah Pharmaceutical Industry. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Rekah Pharmaceutical Industry?

The number of employees can also have an impact on investors of Rekah Pharmaceutical Industry, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Rekah Pharmaceutical Industry affect the company?

An increase in equity of Rekah Pharmaceutical Industry can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Rekah Pharmaceutical Industry's equity affect the company?

A reduction in equity of Rekah Pharmaceutical Industry can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Rekah Pharmaceutical Industry?

Some factors that can influence the equity of Rekah Pharmaceutical Industry include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Rekah Pharmaceutical Industry so important for investors?

The equity of Rekah Pharmaceutical Industry is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Rekah Pharmaceutical Industry influence the company?

The number of employees at Rekah Pharmaceutical Industry can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Rekah Pharmaceutical Industry evolved in recent years?

In recent years, the number of employees at Rekah Pharmaceutical Industry has changed by 0.

How many employees does Rekah Pharmaceutical Industry currently have?

Rekah Pharmaceutical Industry currently has 434 undefined employees.

Why is the number of employees important for investors of Rekah Pharmaceutical Industry?

The number of employees is important for investors of Rekah Pharmaceutical Industry as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Rekah Pharmaceutical Industry take to change the number of employees?

To change the number of employees, Rekah Pharmaceutical Industry can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Rekah Pharmaceutical Industry pay?

Over the past 12 months, Rekah Pharmaceutical Industry paid a dividend of 0.87 ILS . This corresponds to a dividend yield of about 0.06 %. For the coming 12 months, Rekah Pharmaceutical Industry is expected to pay a dividend of 0.87 ILS.

What is the dividend yield of Rekah Pharmaceutical Industry?

The current dividend yield of Rekah Pharmaceutical Industry is 0.06 %.

When does Rekah Pharmaceutical Industry pay dividends?

Rekah Pharmaceutical Industry pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rekah Pharmaceutical Industry?

Rekah Pharmaceutical Industry paid dividends every year for the past 0 years.

What is the dividend of Rekah Pharmaceutical Industry?

For the upcoming 12 months, dividends amounting to 0.87 ILS are expected. This corresponds to a dividend yield of 0.06 %.

In which sector is Rekah Pharmaceutical Industry located?

Rekah Pharmaceutical Industry is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rekah Pharmaceutical Industry kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rekah Pharmaceutical Industry from 4/14/2022 amounting to 0.868 ILS, you needed to have the stock in your portfolio before the ex-date on 4/6/2022.

When did Rekah Pharmaceutical Industry pay the last dividend?

The last dividend was paid out on 4/14/2022.

What was the dividend of Rekah Pharmaceutical Industry in the year 2024?

In the year 2024, Rekah Pharmaceutical Industry distributed 0 ILS as dividends.

In which currency does Rekah Pharmaceutical Industry pay out the dividend?

The dividends of Rekah Pharmaceutical Industry are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rekah Pharmaceutical Industry

Our stock analysis for Rekah Pharmaceutical Industry Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rekah Pharmaceutical Industry Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.